معرفی
Prof. Dr. Rainer Spanagel serves as the Head of the Institute of Psychopharmacology at the Central Institute of Mental Health (ZI) within the Medical Faculty Mannheim of Heidelberg University. His research focuses on addiction neuroscience, particularly alcohol and drug dependence, with a strong emphasis on translational approaches bridging preclinical and clinical research. Key areas include comorbid psychiatric disorders (anxiety, depression, ADHD), neurobiological mechanisms of relapse, and the development of novel therapeutic interventions.
Spanagel's work utilizes advanced methodologies such as transgenic animal models, neuroimaging (MRI/fMRI), and systems medicine approaches. He leads projects on epigenetic modulation (e.g., oxytocin in alcohol addiction), drug repurposing (psilocybin), and the impact of adverse childhood experiences on addictive behaviors. Major grants include EU NEURON, BMBF (AERIAL, Target-OXY), and DFG funding for systems medicine and single-cell sequencing studies.
His research integrates genetic, environmental, and neurochemical factors to address addiction's biological underpinnings. Notable contributions include identifying hyperdopaminergic states in alcohol abstinence and the role of RasGRF2 in cocaine reward pathways. Current initiatives focus on precision medicine strategies for substance use disorders through multi-omics integration and behavioral monitoring.
- Key Research Themes: Translational addiction, neuropharmacology, comorbidity mechanisms, epigenetics.
- Collaborations: Pharmaceutical industry partnerships for preclinical drug trials, multi-institutional consortia (SysMedSUDs, TRR265).
- Facilities: 9.4T MRI for animal neuroimaging, in silico brain banks integrating single-cell omics data.
